Those conditions include the sale of a UTC facility in Danbury.
merger
Posted inPolitics
Feds likely to approve of Raytheon, UTC deal
Although it would boost defense industry consolidation, there is little overlap between Raytheon and UTC that would pose anti-trust issues for the federal government.
Posted inNews
Pentagon to take a ‘hard look’ at Raytheon, UTC tie up
There are also grumblings in Congress about the deal, which would further consolidate the defense industry.
Posted inNews, Politics
UTC-Raytheon merger may hit bumps on way to completion
President Donald Trump and Sen. Richard Blumenthal were among those who voiced concerns on Monday that the merger would hurt competitiveness in the defense industry.
Posted inHealth
Federal judge cast cloud over CVS-Aetna merger
U.S. District Court Judge Richard Leon questioned whether Aetna’s divestiture of its Medicare Part D business was sufficient and has scheduled another round of hearings.
Posted inJustice
Cigna, Anthem, await multi-billion-dollar decision after bitter court fight
A Delaware judge is weighing competing claims by the insurers whose failed merger turned into a messy divorce.
Posted inHealth
CVS says purchase of Aetna is done deal
CVS announced the completion of its purchase of Aetna on Wednesday, promising the new combined company would lead to “improved health outcomes and lower medical costs.”
Posted inHealth
Connecticut Insurance Department approves CVS-Aetna merger
The Connecticut Insurance Department has approved CVS Health Corp’s $69 billion merger with Hartford-based Aetna Inc.
The approval is contingent on Aetna completing the sale of its standalone Medicare Part D prescription plan business.
Posted inHealth
Justice Department approves CVS-Aetna merger, with conditions
WASHINGTON –The Justice Department on Wednesday cleared CVS Health Corp.’s planned $69 billion merger with Aetna Inc. after the companies agreed to divest a Medicare prescription drug plan sold by the Hartford-based health insurer. Consumer groups, however, continue to oppose the deal.
Posted inHealth, Politics
Anthem not giving up on Cigna merger, is appealing to Supreme Court
Updated at 2 p.m.
WASHINGTON — Anthem’s $54 billion merger deal with Cigna is considered to be on life support after a federal appeals court ruled last week it violated antitrust law. But on Friday, Anthem said it is appealing that decision to the U.S. Supreme Court.
Posted inHealth
Appeals court blocks Anthem-Cigna merger
WASHINGTON – A federal appeals court on Friday agreed with a lower court that Anthem’s proposed $54 billion merger with Cigna would be anti-competitive and should not be allowed, but Anthem said it plans to continue pursuing the deal.
Posted inHealth, Politics
Anthem’s cost savings at center of merger suit appeal argument
WASHINGTON — Anthem and the Justice Department faced off in court Friday over the insurer’s proposed merger with Cigna, with the legal wrangling centered on whether any savings from the deal would justify shrinking the market for large employer insurance policies from four to three carriers.
Posted inHealth
In appeal, feds argue merger with Anthem would hurt Cigna’s ‘value-based’ care
WASHINGTON – In its showdown next week with Anthem over a planned merger with Cigna, the Justice Department will make the Bloomfield-based insurer’s unique business model a key part of its argument aimed at swaying an appellate court to reject the $54 billion deal.
Posted inHealth, Politics
AMA ‘alarmed’ political influence could sway DOJ on Anthem-Cigna merger
Updated at 6:25 p.m.
WASHINGTON — The American Medical Association, says it is “alarmed” Anthem may be taking advantage of changes in leadership in the Justice Department that would “bend antitrust laws” and result in a settlement of the federal case that has blocked its merger with Cigna.
Posted inHealth, Politics
Anthem’s pursuit of Cigna still in play, but faces huge hurdles
WASHINGTON — Anthem’s effort to merge with Cigna, which seemed to end with a huge thud when a federal court ruled the $54 billion deal is anti-competitive, may have been given new life – but the odds are long and Connecticut could stand in the way.